I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again.

John Roush Biography and Net Worth

Director of LeMaitre Vascular

John A. Roush has served as a member of our Board of Directors since April 2014. Mr. Roush also serves as a board director and member of the Compensation Committee and Nominating & Corporate Governance Committee for Advanced Energy Industries, Inc. (NASDAQ: AEIS). Mr. Roush served as Chief Executive Officer and a member of the Board of Directors of Novanta Inc., a global supplier of precision photonic components and subsystems to original equipment manufacturers (OEMs) in the medical, industrial, scientific and microelectronics markets, from 2010 to 2016. Prior to joining Novanta Inc., he was a corporate officer and served in several senior leadership positions for twelve years with PerkinElmer, Inc., a provider of technology and services to the diagnostics, research, environmental, safety and security, industrial and laboratory services markets. Since 2009, Mr. Roush had been serving as president of PerkinElmer’s Environmental Health business. From 2004 to 2009, Mr. Roush led PerkinElmer’s Optoelectronics business unit, which supplies specialty photonics products to biomedical and industrial OEMs. From 1999 to 2004, Mr. Roush served in various general management roles within the Optoelectronics business unit. Prior to joining PerkinElmer, Mr. Roush held management positions with Outboard Marine Corporation, AlliedSignal, Inc., now Honeywell International, McKinsey & Company Inc. and General Electric. Mr. Roush received a B.S. in Electrical Engineering from Tufts University and an M.B.A. from the Harvard Business School. The Board has concluded that Mr. Roush should serve on our Board due to his experience at an executive level and his more than 15 years of experience supplying products into the medical device and life sciences industries.

What is John A. Roush's net worth?: The estimated net worth of John A. Roush is at least $231,262.56 as of March 7th, 2024. Mr. Roush owns 2,278 shares of LeMaitre Vascular stock worth more than $231,263 as of November 14th. This net worth estimate does not reflect any other investments that Mr. Roush may own. Learn More about John A. Roush's net worth.
How do I contact John A. Roush?: The corporate mailing address for Mr. Roush and other LeMaitre Vascular executives is 63 SECOND AVENUE, BURLINGTON MA, 01803. LeMaitre Vascular can also be reached via phone at (781) 221-2266. Learn More on John A. Roush's contact information.
Has John A. Roush been buying or selling shares of LeMaitre Vascular?: John A. Roush has not been actively trading shares of LeMaitre Vascular within the last three months. Most recently, John A. Roush sold 7,500 shares of the business's stock in a transaction on Thursday, March 7th. The shares were sold at an average price of $69.00, for a transaction totalling $517,500.00. Following the completion of the sale, the director now directly owns 2,278 shares of the company's stock, valued at $157,182. Learn More on John A. Roush's trading history.
Who are LeMaitre Vascular's active insiders?: LeMaitre Vascular's insider roster includes Trent Kamke (Senior Vice President, Operations), George Lemaitre (CEO), Joseph Pellegrino, Jr. (CFO), David Roberts (Director), and John Roush (Director). Learn More on LeMaitre Vascular's active insiders.
Are insiders buying or selling shares of LeMaitre Vascular?: In the last twelve months, insiders at the medical instruments supplier sold shares 15 times. They sold a total of 291,875 shares worth more than $20,789,758.71. The most recent insider tranaction occured on August, 13th when Director David B Roberts sold 3,063 shares worth more than $251,380.41. Insiders at LeMaitre Vascular own 10.8% of the company. Learn More about insider trades at LeMaitre Vascular.
Information on this page was last updated on 8/13/2024.

John A. Roush Insider Trading History at LeMaitre Vascular

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
3/7/2024	Sell	7,500	$69.00	$517,500.00	2,278
5/9/2023	Sell	7,500	$65.74	$493,050.00	8,669
12/1/2022	Sell	7,500	$46.65	$349,875.00	8,076
5/24/2021	Sell	7,143	$50.25	$358,935.75	14,643
12/8/2020	Sell	20,000	$36.42	$728,400.00	7,500

John A. Roush Buying and Selling Activity at LeMaitre Vascular

LeMaitre Vascular Company Overview

LeMaitre Vascular, Inc. develops, manufactures, and markets medical devices and implants used in the field of vascular surgery worldwide. It offers human cadaver tissue cryopreservation services; angioscope, a fiberoptic catheter used for viewing the lumen of a blood vessel; embolectomy catheters to remove blood clots from arteries; thrombectomy catheters for removing thrombi in the venous system; occlusion catheters that temporarily occlude the blood flow; and perfusion catheters to perfuse the blood and other fluids into the vasculature. The company also provides artegraft biologic graft, a bovine carotid artery used for dialysis access; XenoSure biologic patches, used for closure of vessels after surgical intervention; VascuCel and CardioCel biologic patches, used in vessel repair, heart repair and reconstruction, and neonatal repairs; cardiovascular patches; carotid shunts that temporarily shunt the blood to the brain during the removal of plaque in a carotid endarterectomy surgery; biosynthetic vascular graft indicated for lower extremity bypass and dialysis access; and vascular grafts used to bypass or replace diseased arteries. In addition, it offers radiopaque tape, a medical-grade tape applied to the skin that enables surgeons and interventionalists to cross-refer between the inside and the outside of a patient's body and allows them to locate tributaries or lesions beneath the skin. Further, the company provides valvulotomes, which cut or disrupt valves in the saphenous vein to function as an artery to carry blood past diseased arteries to the lower leg or the foot; and closure systems to attach vessels to one another with titanium clips instead of sutures. It markets its products through a direct sales force and distributors. The company was formerly known as Vascutech, Inc. and changed its name to LeMaitre Vascular, Inc. in April 2001. LeMaitre Vascular, Inc. was incorporated in 1983 and is headquartered in Burlington, Massachusetts.

Today's Range

Now: $101.52

$101.15

$103.52

50 Day Range

MA: $91.56

$85.64

$105.50

2 Week Range

Now: $101.52

$50.42

$106.49

Volume

82,539 shs

Average Volume

124,613 shs

Market Capitalization

$2.28 billion

P/E Ratio

55.48

Dividend Yield

0.62%

Beta

0.89

I was wrong. Dead wrong.

From Porter & Company | Ad